13 June 2023 : Clinical Research
Comparison of Texture and Color Enhancement Imaging with White Light Imaging in 52 Patients with Short-Segment Barrett’s Esophagus
Atsushi Ikeda1BCDEF, Tsutomu Takeda
1ABCDEFG*, Hiroya Ueyama1BCE, Yasuko Uemura1B, Tomoyo Iwano1B, Momoko Yamamoto1B, Ryouta Uchida1B, Hisanori Utsunomiya1B, Shotaro Oki1B, Nobuyuki Suzuki 1B, Daiki Abe1B, Noboru Yatagai1B, Yoichi Akazawa1B, Kumiko Ueda1D, Daisuke Asaoka1D, Tomoyoshi Shibuya1D, Mariko Hojo1D, Shuko Nojiri2C, Akihito Nagahara1ACDEFG
DOI: 10.12659/MSM.940249
Med Sci Monit 2023; 29:e940249
Table 1 Characteristics and endoscopic findings for all 52 patients.
| Characteristics | Value |
|---|---|
| Sex (males/females) | 25/27 |
| Age in years, mean±SD (range) | 64.1±14.2 (33–86) |
| Prague classification | C0M1: 34, C0M2: 4, C1M1: 7C1M2: 2, C2M2: 3, C2M3: 2 |
| Hiatus hernia (±) | 15/37 |
| Reflux esophagitis (±) | 16(LA-M/A/B: 3/10/3)/36 |
| Anti-acid therapy (±) | 24(PPI/PCAB/H2blocker: 15/8/1)/28 |
| Atrophic gastritis (±) | 29(C-1,2,3/O-1,2,3: 16/13)/23 |
| infection status | negative: 23, positive: 5, post-eradication: 24 |
| SD – standard deviation; LA – Los Angeles classification; PPI – proton pump inhibitor; PCAB – potassium competitive acid blocker; H2blocker – H2-receptor antagonist; – | |